Consultants (Voting)

 

Victor Santana, M.D., St. Jude Children’s Hospital

Peter Adamson, M.D., Children’s Hospital of Philadelphia

Alice Ettinger, R.N., Association of Pediatric Oncology Nurses

Jerry Finklestein, M.D., University of California, Los Angeles

Patrick C Reynolds, M.D., Los Angeles Children’s Hospital

Robert Nelson, M.D., Ph.D., The Children's Hospital of Philadelphia

Ruth Hoffman, Candlelighters Children’s Foundation (patient rep.)

Nancy Keene, Independent advocate (patient rep.)

Susan Weiner, Ph.D., Children’s Cause (patient rep.)

 

Guest Speakers (Non-Voting)

 

Malcolm Smith, M.D., Cancer Treatment & Evaluation Program, National Cancer Institute, NIH

Frank Balis, M.D., National Cancer Institute, NIH

Edward Sausville, M.D., National Cancer Institute, NIH

Barry Anderson, M.D., National Cancer Institute, NIH

Bruce Morland, M.D., United Kingdom Children’s Cancer Group

Dave Poplack, M.D., Texas Children’s Cancer Center & Hematology Service, Baylor University

Peter Houghton, M.D., Dept. Molecular Pharmacology, St. Jude Children's Research Hospital

Susan Blaney, M.D., Texas Children's Hospital

Joachim Boos, M.D., University of Muenster, Germany

Eric Kodish, M.D., Rainbow Center for Pediatric Ethics, Case Western Reserve University

 

Industry Attendees (Non-Voting)

Judith Ochs, M.D., Astra Zeneca Pharmaceuticals

Anne Hagey, M.D., Abbott Laboratories Global Oncology Development Group

David Emanuel, M.D., Pharmacia

Steven Weitman, M.D., Ilex Oncology Inc.

Wayne Rackoff, M.D., Johnson & Johnson Pharmaceutical Research & Development